The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of GLP1-RA with PCSK9i as chemosensitizing method and therapy of anthracycline-induced cardiotoxicity under exposure to Ox-LDL: Biochemical and preclinical evidences.
 
Vincenzo Quagliariello
No Relationships to Disclose
 
Maria Canale
No Relationships to Disclose
 
Irma Bisceglia
No Relationships to Disclose
 
Martina Iovine
No Relationships to Disclose
 
Marino Scherillo
No Relationships to Disclose
 
Alessandro Inno
No Relationships to Disclose
 
Christian Cadeddu Dessalvi
No Relationships to Disclose
 
Massimiliano Berretta
No Relationships to Disclose
 
Domenico Gabrielli
No Relationships to Disclose
 
Matteo Barbato
No Relationships to Disclose
 
Fabrizio Maurea
No Relationships to Disclose
 
Ilaria Giacobbe
No Relationships to Disclose
 
Michelino De Laurentiis
Stock and Other Ownership Interests - Arvinas
Honoraria - AstraZeneca; Daiichi Sankyo Europe GmbH; Exact Sciences; Gilead Sciences; Ipsen; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen; TOMA Biosciences; Veracyte
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo Europe GmbH; Gilead Sciences; Ipsen; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Speakers' Bureau - Novartis
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Genzyme (Inst); Lilly; MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Nicola Maurea
No Relationships to Disclose